Is the price fair?
What STVN's price assumes
Stevanato Group S.p.A. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 1.26× revenue.
1.26
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.68
Price / book · as of 2025-FY
- EV / sales
- 1.33
EV / sales
Details›
- Price / book2025-FY
- 3.68
- EV / EBIT2025-FY
- 7.70
- EV / sales2025-FY
- 1.33
- Market capitalisation
- $4.79B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #13 of 27 by Smart Score